Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald D Alvarez

Showing results (41-50 of 211) with videos related to

Pageof 22
Sort By:
Obstetrics and Gynecology|October 5, 2006
Inflammatory pseudotumor of pelvic lymph nodesWhitney A Spannuth, Charles A Leath, Michael G Conner, et al.
Experimental Cell Research|January 22, 2013
Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulationHuaping Chen, Charles N Landen, Yuanyuan Li, et al.
Gynecologic Oncology|November 19, 2020
Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancerFa Chen, Christina E Bailey, Ronald D Alvarez, et al.
Journal of Oncology|March 12, 2013
Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and SulforaphaneHuaping Chen, Charles N Landen, Yuanyuan Li, et al.
American Journal of Obstetrics and Gynecology|November 13, 2019
Survival outcomes for robotic-assisted laparoscopy versus traditional laparoscopy in clinical stage I epithelial ovarian cancerBenjin Facer, Fei Wang, Carlos G Grijalva, et al.
Plos One|January 30, 2013
A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folateChandrika J Piyathilake, Suguna Badiga, Ronald D Alvarez, et al.
Molecular Cancer Therapeutics|December 13, 2002
Conditionally replicative adenoviruses for ovarian cancer therapyMack N Barnes, Candace J Coolidge, Akseli Hemminki, et al.
Gynecologic Oncology|July 22, 2006
Unilateral cervical cancer in a patient with cervix duplexKristopher J Kimball, Rodney P Rocconi, J Michael Straughn, et al.
Gynecologic Oncology|July 19, 2013
Folate and folate receptor alpha antagonists mechanism of action in ovarian cancerChristen L Walters, Rebecca C Arend, Deborah K Armstrong, et al.
Gynecologic Oncology|July 19, 2013
Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancerKhursheed Anwer, F Joseph Kelly, Christina Chu, et al.
Pageof 22

Showing results (41-50 of 211) with videos related to

Sort By:
Pageof 22
Obstetrics and Gynecology|October 5, 2006
Inflammatory pseudotumor of pelvic lymph nodesWhitney A Spannuth, Charles A Leath, Michael G Conner, et al.
Experimental Cell Research|January 22, 2013
Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulationHuaping Chen, Charles N Landen, Yuanyuan Li, et al.
Gynecologic Oncology|November 19, 2020
Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancerFa Chen, Christina E Bailey, Ronald D Alvarez, et al.
Journal of Oncology|March 12, 2013
Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and SulforaphaneHuaping Chen, Charles N Landen, Yuanyuan Li, et al.
American Journal of Obstetrics and Gynecology|November 13, 2019
Survival outcomes for robotic-assisted laparoscopy versus traditional laparoscopy in clinical stage I epithelial ovarian cancerBenjin Facer, Fei Wang, Carlos G Grijalva, et al.
Plos One|January 30, 2013
A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folateChandrika J Piyathilake, Suguna Badiga, Ronald D Alvarez, et al.
Molecular Cancer Therapeutics|December 13, 2002
Conditionally replicative adenoviruses for ovarian cancer therapyMack N Barnes, Candace J Coolidge, Akseli Hemminki, et al.
Gynecologic Oncology|July 22, 2006
Unilateral cervical cancer in a patient with cervix duplexKristopher J Kimball, Rodney P Rocconi, J Michael Straughn, et al.
Gynecologic Oncology|July 19, 2013
Folate and folate receptor alpha antagonists mechanism of action in ovarian cancerChristen L Walters, Rebecca C Arend, Deborah K Armstrong, et al.
Gynecologic Oncology|July 19, 2013
Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancerKhursheed Anwer, F Joseph Kelly, Christina Chu, et al.
Pageof 22